|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date12 Sep 2013 |
100 Clinical Results associated with Retrophin Europe Ltd.
0 Patents (Medical) associated with Retrophin Europe Ltd.
100 Deals associated with Retrophin Europe Ltd.
100 Translational Medicine associated with Retrophin Europe Ltd.